{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Potential AI/ML Learnings to Come from FDA Public Advisory Committee Meeting on Skin Lesion Analyzer Technology in Late July",
"url": "https://www.lexblog.com/2022/06/22/potential-ai-ml-learnings-to-come-from-fda-public-advisory-committee-meeting-on-skin-lesion-analyzer-technology-in-late-july/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-P16X7JRR",
"url": "https://www.lexblog.com/lib/P16X7JRR/"
},
"datePublished": "2022-06-22T13:30:05-04:00",
"dateModified": "2022-06-22T17:16:35-04:00",
"author": {
"@type": "Person",
"name": "Emily Tribulski|Stephanie Philbin"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Goodwin Procter"
},
"organizationScope": "at-publication",
"isPartOf": "Life Sciences Perspectives",
"about": "Health Care and Life Sciences",
"sourceUrl": "https://www.lifesciencesperspectives.com/2022/06/22/potential-ai-ml-learnings-to-come-from-fda-public-advisory-committee-meeting-on-skin-lesion-analyzer-technology-in-late-july/",
"sourceStability": "may-move"
}